Hemoglobin e and glucose-6-phosphate dehydrogenase deficiency and plasmodium falciparum malaria in the chittagong hill districts of Bangladesh

American Journal of Tropical Medicine and Hygiene

Volumn 93, Issue 2, 2015, Pages 281-286

  Shannon, Kerry L ^b   Ahmed, Sabeena ^b   Rahman, Hafizur ^b   Prue, Chai S ^b   Khyang, Jacob ^b   Ram, Malathi ^b   Haq, M Zahirul ^b   Chowdhury, Ashish ^b   Akter, Jasmin ^b   Glass, Gregory E ^b   Shields, Timothy ^b   Nyunt, Myaing M ^b   Khan, Wasif A ^b   Sack, David A ^b   Sullivan, David J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A; HEMOGLOBIN A2; HEMOGLOBIN E; HEMOGLOBIN F; HEMOGLOBIN H;

ADULT; ALPHA THALASSEMIA; ARTICLE; BANGLADESH; BETA CHAIN; BETA THALASSEMIA; BLOOD SAMPLING; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN ANALYSIS; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; POPULATION SIZE; SENSITIVITY ANALYSIS; BLOOD; CROSS-SECTIONAL STUDY; DEFICIENCY; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; METABOLISM; PLASMODIUM FALCIPARUM; PREVALENCE; YOUNG ADULT;

PLASMODIUM FALCIPARUM;

ADULT; BANGLADESH; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN E; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PREVALENCE; YOUNG ADULT;

EID: 84939241099     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0623     Document Type: Article

References (26)

1. Agarwal A, Guindo A, Cissoko Y, Taylor JG, Coulibaly D, Kone A, Kayentao K, Djimde A, Plowe CV, Doumbo O, Wellems TE, Diallo D, 2000. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a west African population with a low prevalence of hemoglobin S. Blood 96: 2358-2363.
2. Modiano D, Luoni G, Sirima BS, Simpore J, Verra F, Konate A, Rastrelli E, Olivieri A, Calissano C, Paganotti GM, D'Urbano L, Sanou I, Sawadogo A, Modiano G, Coluzzi M, 2001. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 414: 305-308.
3. Mockenhaupt FP, Ehrhardt S, Cramer JP, Otchwemah RN, Anemana SD, Goltz K, Mylius F, Dietz E, Eggelte TA, Bienzle U, 2004. Hemoglobin C and resistance to severe malaria in Ghanaian children. J Infect Dis 190: 1006-1009.
4. May J, Evans JA, Timmann C, Ehmen C, Busch W, Thye T, Agbenyega T, Horstmann RD, 2007. Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA 297: 2220-2226.
5. Williams TN, Mwangi TW, Wambua S, Alexander ND, Kortok M, Snow RW, Marsh K, 2005. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis 192: 178-186.
6. Fucharoen S, Winichagoon P, 1987. Hemoglobinopathies in southeast Asia. Hemoglobin 11: 65-88.
7. Naka I, Ohashi J, Nuchnoi P, Hananantachai H, Looareesuwan S, Tokunaga K, Patarapotikul J, 2008. Lack of association of the HbE variant with protection from cerebral malaria in Thailand. Biochem Genet 46: 708-711.
8. Williams TN, 2006. Human red blood cell polymorphisms and malaria. Curr Opin Microbiol 9: 388-394.
9. Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Brittenham G, Looareesuwan S, Clark AG, Tokunaga K, 2004. Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection. Am J Hum Genet 74: 1198-1208.
10. Haldane J, 1949. The rate of mutation of human genes. Hereditas 35: 267-273.
11. Hutagalung R, Wilairatana P, Looareesuwan S, Brittenham GM, Aikawa M, Gordeuk VR, 1999. Influence of hemoglobin E trait on the severity of falciparum malaria. J Infect Dis 179: 283-286.
12. Oo M, Tin S, Marlar T, O'Sullivan WJ, 1995. Genetic red cell disorders and severity of falciparum malaria in Myanmar. Bull World Health Organ 73: 659-665.
13. Hutagalung R, Wilairatana P, Looareesuwan S, Brittenham GM, Gordeuk VR, 2000. Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives. J Infect Dis 181: 1513-1516.
14. Ahmed S, Galagan S, Scobie H, Khyang J, Prue CS, Khan WA, Ram M, Alam MS, Haq MZ, Akter J, Glass G, Norris DE, Nyunt MM, Shields T, Sullivan DJ, Sack DA, 2013. Malaria hotspots drive hypoendemic transmission in the Chittagong Hill Districts of Bangladesh. PLoS One 8: e69713.
15. Khan WA, Sack DA, Ahmed S, Prue CS, Alam MS, Haque R, Khyang J, Ram M, Akter J, Nyunt MM, Norris D, Glass G, Shields T, Haq MZ, Cravioto A, Sullivan DJ Jr, 2011. Mapping hypoendemic, seasonal malaria in rural Bandarban, Bangladesh: a prospective surveillance. Malar J 10: 124.
16. Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R, Lek S, Muth S, Chea N, Chuor CM, Duong S, Kerleguer A, Tor P, Chim P, Canier L, Witkowski B, Taylor WR, Menard D, 2013. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients. Malar J 12: 171.
17. Team RR, 2008. A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
18. Alperin JB, Dow PA, Petteway MB, 1977. Hemoglobin-A2 levels in health and various hematologic disorders. Am J Clin Pathol 67: 219-226.
19. Billo MA, Johnson ES, Doumbia SO, Poudiougou B, Sagara I, Diawara SI, Diakite M, Diallo M, Doumbo OK, Tounkara A, Rice J, James MA, Krogstad DJ, 2012. Sickle cell trait protects against Plasmodium falciparum infection. Am J Epidemiol 176 (Suppl 7): S175-S185.
20. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ, 2014. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371: 411-423.
21. Starzengruber P, Swoboda P, Fuehrer HP, Khan WA, Hofecker V, Siedl A, Fally M, Graf O, Teja-Isavadharm P, Haque R, Ringwald P, Noedl H, 2012. Current status of artemisininresistant falciparum malaria in south Asia: a randomized controlled artesunate monotherapy trial in Bangladesh. PLoS One 7: e52236.
22. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, Consortium AS, 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 2619-2620.
23. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, Rutvisuttinunt W, Bethell D, Surasri S, Fukuda MM, Socheat D, Thap LC, 2010. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in southeast Asia. Clin Infect Dis 51: E82-E89.
24. Li QG, O'Neil M, Xie LS, Caridha D, Zeng Q, Zhang J, Pybus B, Hickman M, Melendez V, 2014. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections. Malar J 13: 141.
25. Fernando D, Rodrigo C, Rajapakse S, 2011. Primaquine in vivax malaria: an update and review on management issues. Malar J 10: 351.
26. Global Malaria Programme, 2012. Single Dose Primaquine as a Gametocytocide in Plasmodium falciparum Malaria. Available at: http://www.who.int/malaria/mpac/sep2012/en/.